Business Context and Reporting Period
Company: Compass Minerals International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 28, 2024
Subject: Non-reliance on previously issued financial statements and announcement of a restatement.
The Audit Committee determined that financial statements for the periods ended June 30, 2023, September 30, 2023, December 31, 2023, and March 31, 2024, should no longer be relied upon due to misstatements. The Company plans to restate these periods in amended Form 10-K and Form 10-Q filings.
Key Financial Metrics and Adjustments
The filing details preliminary estimates of restatement adjustments related to the fair value of a milestone contingent consideration liability from the Fortress acquisition. The filing does not provide updated total revenue, profit, or cash flow figures for the current period, only the specific adjustments to prior periods.
| Period | Line Item | Adjustment (in millions) |
|---|---|---|
| Fiscal 2024 Q1 | Other operating expense (income) | $(1.3) |
| Operating earnings | $1.3 | |
| Adjusted EBITDA understatement | $1.1 | |
| Fiscal 2024 Q2 | Loss on impairments | $(8.0) |
| Other operating expense (income) | $0.5 | |
| Operating earnings | $7.5 | |
| Fiscal 2023 Q3 | Loss from remeasurement of equity method investment | $3.6 |
| Adjusted EBITDA understatement | $9.0 | |
| Fiscal 2023 Q4 | Selling, general and administrative expenses | $(0.2) |
| Operating earnings | $0.2 |
Balance Sheet Adjustments (Unaudited):
- March 31, 2024: Goodwill $0; Total Assets $0; Retained Earnings $5.4 million increase; Total Stockholders' Equity $5.4 million increase.
- September 30, 2023: Goodwill $(8.0) million; Total Assets $(8.0) million; Retained Earnings $(3.4) million; Total Stockholders' Equity $(3.4) million.
Material Changes and Causes
The misstatements stem from a failure to factor the option value of potential share settlement into the fair value of a milestone contingent consideration liability (up to $28 million) associated with the Fortress acquisition dated May 5, 2023. This error affected:
- The initial purchase price allocation.
- The ongoing fair value of the liability in subsequent quarters.
Additionally, the Company identified immaterial misstatements in the historical presentation of Consolidated Statements of Cash Flows regarding non-cash capital expenditures in accounts payable. These were previously corrected voluntarily for interim periods ended March 31, 2023, and December 31, 2023, but will be reflected in the amended filings.
Outlook, Risks, and Management Commentary
Restatement Plan: The Company intends to file an amendment to the 2023 Form 10-K and the Q2 2024 Form 10-Q as soon as reasonably practical to restate the affected periods.
Internal Controls: The Company is evaluating the effectiveness of its internal control over financial reporting and disclosure controls. It expects to report one or more material weaknesses due to the identified misstatements.
Uncertainty: Management states that the review is not fully complete. The financial impact described is preliminary and subject to change. The Company cannot assure that other errors will not be identified.
Forward-Looking Statements: The report includes standard disclaimers regarding risks that actual results may differ from estimates, including risks related to the restatement process and methodology.
Investor Verification Checklist
- Verify the final restated financial figures in the upcoming amended 2023 Form 10-K and Q2 2024 Form 10-Q.
- Confirm the specific nature and scope of the material weaknesses in internal controls once disclosed in the amended filings.
- Monitor for any additional errors identified during the ongoing review process.
- Review the corrected Consolidated Statements of Cash Flows for the interim periods.
- Assess the impact of the Adjusted EBITDA corrections ($1.1 million in Q1 2024 and $9.0 million in Q2 2024) on non-GAAP performance metrics.